Pharmaceutical Product Supply – Potassium Chloride Tablets

The contract obligates the supplier to manufacture and deliver FDA-approved Potassium Chloride Extended-Release Tablets, 20 mEq, packaged in 100-count bottles, fully compliant with United States Pharmacopeia standards and military National Stock Number specifications. The product must meet stringent quality and regulatory requirements to ensure safety, efficacy, and consistency for use by the Department of Defense. Manufacturing processes, packaging, and labeling must align with current Good Manufacturing Practices and all applicable federal regulations governing pharmaceutical products distributed through defense logistics channels. The contract is classified as a subcontract under NAICS code 325412, indicating it falls within the pharmaceutical and medicine manufacturing sector. It is issued by the Defense Logistics Agency, part of the Department of Defense, and the product will be delivered to support military medical needs. The solicitation was posted on July 16, 2026, and the contract has been awarded under reference number SPE2DX25D8022 with delivery order SPE2D926F7404, with a total of 8,849 units involved. All supplies must be produced and shipped according to strict defense procurement protocols, ensuring traceability, compliance, and readiness for deployment in military healthcare settings.